HOPE
In 2001, Tom experienced a devastating loss when his beloved mother succumbed to Parkinson’s disease. Alongside the grief, Tom’s family carried the frustration of witnessing her gradual deterioration from her vibrant self to experiencing involuntary movements, depression, and the eventual frozen expression that preceded her passing.
Tom’s Groundbreaking Study
Two decades later, Tom stood as the driving force behind an Institutional Review Board-approved placebo-controlled Parkinson’s and multiple sclerosis study. His groundbreaking research accomplished something unprecedented in the last 207 years – the proving that James Parkinson’s “Shaking Palsy”, described back in 1817, can be significantly reversed.
Advanced proteomic studies revealed in 2019 that we are biologically programed to age and that our plasma controls that aging process. Tom has now proven that putting plasma from sex-identified young donors into aged individuals rejuvenates their cells and tissues more effectively than any previous therapy.
While Tom’s current achievements have had a significant personal impact, his journey towards scientific innovation remains strong and unwavering. Tom considers Renewable Regeneration, his program to advance the World’s current blood banking system simply and safely to immediately and significantly improve multigenerational health, his greatest endeavor.
Case Study
Case study of an 82-year-old wife suffering from severe Alzheimer’s disease whose husband provided permission to share his documentation of her amazing recovery (which will continue to be monitored)
Originally arriving in Houston comatose in a wheelchair and unable to read
or recognize anyone, within weeks of receiving 7-liters of yFFP Karen is now enjoying disco dancing, winning at Wordle, interacting with friends and family, and just walked a number of lengthy NYC blocks to breakfast and back
without assistance.
82-year-old female @ deaths doorstep, innocently doomed because she inherited double APOE4 genes, now can walk, talk , converse plus a lot more. The miracle is here & now yFFP.
Karen’s joyful recovery and smile shines in direct contradiction of the National Institute of Aging’s definition of Alzheimer's outcomes (Alzheimers.gov is managed by the National Institute on Aging):
There is currently no cure for Alzheimer's disease. Once the disease process begins, brain cells are permanently damaged and lost, and that damage cannot be reversed.
Medically speaking, there are no documented cases of full, permanent recovery from Alzheimer’s disease. It is a progressive, neurodegenerative condition. While some treatments can help manage symptoms or slow cognitive decline, the brain damage caused by Alzheimer’s is currently considered irreversible.
With researchers estimating that 42% of Americans over age 55 will eventually develop dementia (https://www.nih.gov/news-events/nih-research-matters/risk-future-burden-dementia-united-states) and roughly 70% of the approximate 1 million Americans residing in assisted living communities having some form of memory impairment, the total annual cost in the US to treat Alzheimer's disease and related dementias was estimated to be $781 billion
for 2025.
Given 90% of our $5.3 trillion in healthcare costs are spent on treating chronic and age-related conditions of which individuals aged 55 and over account for 57% of those costs, it will hopefully be of further insight that our “Young Plasma Infusions Significantly Improve Clinical Symptoms and UPDRS Scores in Patients with Parkinson's Disease” is now available on medRxiv
https://medrxiv.org/cgi/content/short/2026.05.12.26353041v1 .
Alzheimer's disease was first identified in 1906 and given recovery from it has been one of medicine’s long sought “holy grails”, the systemic nature of yFFP treatments should guide everyone regardless of their objectives to the observation that as Harvard stated in 2023, “biology is a software problem.”
We now realize our tissues and cells are the hardware and plasma is the software that controls cellular regeneration and programmed aging
Biologically preserved and quantumly and compositionally complex beyond our current understanding, plasma peaks only during a brief eight-year window in human lifespan (18-25). Its beauty is not the targeting of any specific condition but its triggering (volume related) every cell in our bodies - from our bones to our brain.
Adding to that beauty is the fact that frequent donations of plasma clean the blood and dramatically reduces the systemic inflammation that causes chronic diseases. Four paid plasma donations in amonth are the therapeutic volume equivalent of a total plasma exchange that a private provider would charge $10,000. Longevity starts when you are young and at Spectrum Plasma students can earn $5,000 per year by donating weekly, receiving a medical exam and pathogen testing with each donation while cumulatively realizing a $100K therapeutic benefit.
The collection and therapeutic use of yFFP can save the United States economy approximately $1.7+ trillion annually through improving the health of our young while treating age-related diseases.